Effects of nutritional status and dietetic interventions on survival in Cystic Fibrosis patients before and after lung transplantation

被引:51
|
作者
Hollander, F. M. [1 ,2 ]
van Pierre, D. D. [3 ]
de Roos, N. M. [3 ]
van de Graaf, E. A. [2 ]
Iestra, J. A. [4 ]
机构
[1] Univ Med Ctr Utrecht, Dept Dietet, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Cyst Fibrosis & Lung Transplantat Ctr, NL-3508 GA Utrecht, Netherlands
[3] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands
[4] Univ Med Ctr Utrecht, Dept Publ Hlth, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
关键词
Cystic Fibrosis; Lung transplantation; Nutritional status; Nutritional intervention; Body Mass Index; Fat Free Mass; FAT-FREE MASS; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; BODY-COMPOSITION; WEIGHT-GAIN; ADULTS; INDEX; BIOIMPEDANCE; IMPEDANCE; DEPLETION; SUPPORT;
D O I
10.1016/j.jcf.2013.08.009
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: This study retrospectively investigated nutritional status, dietetic intervention and intake in Cystic Fibrosis (CF) patients before and after lung transplantation (LTX). Methods: Body Mass Index (BMI), Fat Free Mass Index (FFMI) and nutritional intake were retrieved from 75 out-patients aged 15-53 years. Patients were seen every 3-4 months during the waiting list time (range 0-81 months) and up to 116 months after LTX. Survival was measured in months. Results: The median BMI at baseline was 19.2 kg/m(2) (range: 15.3 to 28.4 kg/m(2)) with 29 patients (39%) below <= 18.5 kg/m(2). FFMI (measured in 65 patients) had a median of 15.2 kg/m(2) (range: 11.1 to 22.4 kg/m(2)) with 39 patients (60%) <= 16.7 kg/m(2) (men) or <= 14.6 kg/m(2) (women). Median energy intake was 2800 kcal, 239 kcal higher than the estimated energy requirement. However, 8 patients consumed >= 500 kcal less than recommended. Protein intake was 104 (range 60-187) g or 1.9 g/kg per day. Despite dietetic intervention with oral nutritional supplements (ONS) (36 patients), tube feeding (12 patients), or both (13 patients), HMI and FFMI hardly improved pre-LTX. LTX was performed in 51 patients (68%); 10 patients died during follow-up, median survival time was 41 months. A BMI 18.5 kg/m(2) was more prevalent in patients who died before LTX (6/9) or who died after LTX (4/10) than in patients who were still alive on the waiting list (5/15) or who survived LTX (14/41). Results for FFMI were comparable. From 6-12 months post-LTX, BMI and FFMI markedly improved, especially in underweight patients. Conclusion: A BMI <= 18.5 kg/m(2) and an FFMI <= 16.7 kg/m(2) (men) or <= 14.6 kg/m(2) (women) appears to impair survival in LTX candidates with CF. Patients maintained a low body weight before LTX. After LTX weight gain is achieved. CD (C) 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:212 / 218
页数:7
相关论文
共 50 条
  • [41] Improved Survival after Repeat Lung Transplantation at Cystic Fibrosis Care Centers
    Chidi, A. P.
    Krishnan, A.
    Nolley, E.
    Agbor-Enoh, S.
    West, N. E.
    Tallarico, E.
    Thaxton, A.
    Orens, J. B.
    Ha, J. S.
    Shah, P. D.
    Segev, D.
    Massie, A.
    Higgins, R. S.
    Merlo, C. A.
    Bush, E. L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S390 - S390
  • [42] Survival in Patients with Advanced Non-cystic Fibrosis Bronchiectasis Versus Cystic Fibrosis on the Waitlist for Lung Transplantation
    Hayes, Don, Jr.
    Kopp, Benjamin T.
    Tobias, Joseph D.
    Woodley, Frederick W.
    Mansour, Heidi M.
    Tumin, Dmitry
    Kirkby, Stephen E.
    LUNG, 2015, 193 (06) : 933 - 938
  • [43] Human leukocyte antigen mismatching and survival after lung transplantation in adult and pediatric patients with cystic fibrosis
    Hayes, Don, Jr.
    Auletta, Jeffery J.
    Whitson, Bryan A.
    Black, Sylvester M.
    Kirkby, Stephen
    Tobias, Joseph D.
    Mansour, Heidi M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (02): : 549 - U391
  • [44] Survival in Patients with Advanced Non-cystic Fibrosis Bronchiectasis Versus Cystic Fibrosis on the Waitlist for Lung Transplantation
    Don Hayes
    Benjamin T. Kopp
    Joseph D. Tobias
    Frederick W. Woodley
    Heidi M. Mansour
    Dmitry Tumin
    Stephen E. Kirkby
    Lung, 2015, 193 : 933 - 938
  • [45] Cystic fibrosis and lung transplantation - Determination of the survival benefit
    Aigner, C
    Jaksch, P
    Seebacher, G
    Mazhar, S
    Wisser, W
    Klepetko, W
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (9-10) : 318 - 321
  • [46] Survival benefit of lung transplantation for cystic fibrosis in Norway
    Pathak, Sharad
    Durheim, Michael T.
    Finstad, Pal L.
    Holm, Are M.
    Leuckfeld, Inga
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [47] Lung transplantation and survival in children with cystic fibrosis - Reply
    Liou, Theodore G.
    Adler, Frederick R.
    Cox, David R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (16): : 1755 - 1755
  • [48] CURRENT STATUS OF LUNG TRANSPLANTATION FOR CYSTIC-FIBROSIS
    SHENNIB, H
    ADOUMIE, R
    NOIRCLERC, M
    ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (08) : 1585 - 1588
  • [49] THE PROGRESSION OF CYSTIC FIBROSIS-RELATED DIABETES (CFRD) BEFORE AND AFTER LUNG TRANSPLANTATION
    Valenzuela, E.
    Pelaez, A.
    Lascano, J.
    Chandrashekaran, S.
    Leey, J. A.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S470 - S470
  • [50] COMPARISON OF NUTRITIONAL-STATUS IN PATIENTS BEFORE AND AFTER CARDIAC TRANSPLANTATION
    GRADY, KL
    HEROLD, LS
    CIRCULATION, 1987, 76 (04) : 145 - 145